Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04966481
Title	Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
Recruitment	Recruiting
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	Washington University School of Medicine
Indications	hypopharynx cancer oral squamous cell carcinoma head and neck squamous cell carcinoma oropharynx cancer laryngeal squamous cell carcinoma
Therapies	Cetuximab + Palbociclib Cetuximab
Age Groups:	adult \| senior
Covered Countries	USA